Phenylalanyl-tRNA synthetase (PheRS, FARS, or FRS) displays elevated expression levels in many cancers compared to their healthy counterparts according to the database “Gene Expression across Normal and Tumor tissue” (GENT2; [11]). Here, FARSA is linked to neoplasm.